Clinical effects of combined treatment of traditional Chinese medicine and western medicine for viral hepatitis B cirrhosis and the effects on serum miR-122, miR-200a

ABSTRACT

The aim is to explore the clinical effects of combined treatment of Traditional Chinese Medicine (TCM) and western medicine in viral hepatitis B cirrhosis and the effects on microRNA (miR)-122 and miR-200a. 116 patients with chronic hepatitis B cirrhosis were admitted to our hospital. Real-time fluorescent quantitative PCR (qPCR) was employed to reveal the level of serum miR-122 and miR-200a in the three groups. The clinical effects of the two groups were compared, including alanine aminotransferase (ALT), aspartate amino transferase (AST), total bilirubin (TBIL) and alpha fetoprotein (AFP) indexes, coagulation function indexes, liver elasticity value and the main therapeutic effects. After treatment, the ALT, AST, TBIL and AFP indexes significantly decreased in both groups, which were much lower in the western medicine (WM) + TCM Group. The levels of albumin (ALB) all increased, and the increase was more significant in the WM + TCM Group. The prothrombin time (PT) was down-regulated while the prothrombin activity (PTA) was up-regulated in both groups. Both groups showed a decrease in liver elasticity after treatment, which was more obvious in the WM + TCM Group. The incidence of primary peritonitis, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding and electrolyte disturbance in the WM + TCM Group was significantly lower than those in the WM Group. The combination of Chinese and western medicine in the treatment of cirrhosis can reduce the occurrence of complications, improve the clinical symptoms and improve the clinical effects effectively, which is worthy of further study and clinical popularization. Viral hepatitis B, Liver cirrhosis, Combination of TCM and Western medicine, miR-122, miR-200a

KEYWORDS:

• Viral hepatitis B
• liver cirrhosis
• combination of TCM and western medicine
• miR-122
• miR-200a

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The datasets used and/or analyzed during the present study are available from the corresponding author on reasonable request.

Ethics approval and consent to participate

It has been observed that the experimentation involving human subjects has been done in this study. The study was approved by the Ethics Committee of Yantai Qishan Hospital, Yantai, China.

Human and animal rights

Please add the details of the guidelines followed for the experimentation on human subjects.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Notes on contributors

Xiaofan You

Xiaofan You, a technician in charge, has been engaged in inspection work for 10 years, and is proficient in the technology of blood and body fluid inspection and biological diagnosis.

Fen Jiang

Fen Jiang, deputy chief physician of Qishan Hospital in Yantai, Shandong Province, master candidate, specializes in the treatment of common internal diseases and infectious diseases with integrated Chinese and western medicine, deputy chief physician of Qishan Hospital in Yantai, Shandong Province, master candidate, specializes in the treatment of common internal diseases and infectious diseases with integrated Chinese and western medicine.

Yiliang Zhang

Yiliang Zhang, Deputy Director technician, has been engaged in laboratory work for more than 30 years and is proficient in clinical biochemistry and biological diagnosis.